Sabbatini P - Search Results

1

Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study.

Konner JA, Bell-McGuinn KM, Sabbatini P, Hensley ML, Tew WP, Pandit-Taskar N, Vander Els N, Phillips MD, Schweizer C, Weil SC, Larson SM, Old LJ. Konner JA, et al. Among authors: sabbatini p. Clin Cancer Res. 2010 Nov 1;16(21):5288-95. doi: 10.1158/1078-0432.CCR-10-0700. Epub 2010 Sep 20. Clin Cancer Res. 2010. PMID: 20855460 Clinical Trial.

2

Salvage therapy for ovarian cancer.

Sabbatini P, Spriggs D. Sabbatini P, et al. Oncology (Williston Park). 1998 Jun;12(6):833-43; discussion 844-6, 848, 851. Oncology (Williston Park). 1998. PMID: 9644684 Free article. Review.

3

Intraperitoneal chemotherapy strategies in the treatment of epithelial ovarian carcinoma.

Makhija S, Sabbatini P, Barakat RR. Makhija S, et al. Among authors: sabbatini p. Curr Opin Obstet Gynecol. 1999 Feb;11(1):23-7. doi: 10.1097/00001703-199901000-00005. Curr Opin Obstet Gynecol. 1999. PMID: 10047959 Review.

4

Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer.

Sabbatini P, Larson SM, Kremer A, Zhang ZF, Sun M, Yeung H, Imbriaco M, Horak I, Conolly M, Ding C, Ouyang P, Kelly WK, Scher HI. Sabbatini P, et al. J Clin Oncol. 1999 Mar;17(3):948-57. doi: 10.1200/JCO.1999.17.3.948. J Clin Oncol. 1999. PMID: 10071289 Clinical Trial.

5

Implementation of disease management guidelines in patients with advanced ovarian cancer.

Hensley ML, Sabbatini P, Spriggs D. Hensley ML, et al. Among authors: sabbatini p. Semin Oncol. 1999 Feb;26(1 Suppl 1):46-51. Semin Oncol. 1999. PMID: 10071973 Review.

6

Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer.

Husain A, Sabbatini P, Spriggs D, Fennelly D, Aghajanian C, Barakat R, Curtin J, Venkatraman E, Hoskins W, Markman M. Husain A, et al. Among authors: sabbatini p. Gynecol Oncol. 1999 Apr;73(1):96-101. doi: 10.1006/gyno.1998.5317. Gynecol Oncol. 1999. PMID: 10094887 Clinical Trial.

7

Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial.

Sabbatini PJ, Kudryashov V, Ragupathi G, Danishefsky SJ, Livingston PO, Bornmann W, Spassova M, Zatorski A, Spriggs D, Aghajanian C, Soignet S, Peyton M, O'Flaherty C, Curtin J, Lloyd KO. Sabbatini PJ, et al. Int J Cancer. 2000 Jul 1;87(1):79-85. Int J Cancer. 2000. PMID: 10861456 Clinical Trial.

8

Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look.

Makhija S, Sabbatini P, Aghajanian C, Venkatraman E, Spriggs DR, Barakat R. Makhija S, et al. Among authors: sabbatini p. Gynecol Oncol. 2000 Oct;79(1):28-32. doi: 10.1006/gyno.2000.5890. Gynecol Oncol. 2000. PMID: 11006026 Clinical Trial.

9

Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.

Hensley ML, Lebeau D, Leon LF, Venkatraman E, Waltzman R, Sabbatini P, Almadrones L, Chi D, Spriggs D. Hensley ML, et al. Among authors: sabbatini p. Gynecol Oncol. 2001 Jun;81(3):485-9. doi: 10.1006/gyno.2001.6185. Gynecol Oncol. 2001. PMID: 11371143

10

The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients.

Hensley ML, Hoppe B, Leon L, Sabbatini P, Aghajanian C, Chi D, Spriggs DR. Hensley ML, et al. Among authors: sabbatini p. Gynecol Oncol. 2001 Sep;82(3):464-9. doi: 10.1006/gyno.2001.6299. Gynecol Oncol. 2001. PMID: 11520141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters